Document is current

Article History

Received: 26 September 2024

Accepted: 8 December 2024

First Online: 6 January 2025

Declarations

:

: In this retrospective study we used anonymized data from patients treated at Thoraxklinik Heidelberg. For this, ethical approval was obtained from the ethics committee of the University of Heidelberg (S-621/2023).

: The present manuscript was not supported by any external donors. Irrespective of this, the following grants or fees were paid to the individual authors in the last 36 months:ASD received a grant and charges for registry analysis by the German CF Foundation. KK received consulting fees from Cook Medical as well as presentation fees from AstraZeneca, Berlin Chemie, Boston Scientific and Olympus and received travel grants from AstraZeneca. FT received speaker honoraria from Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Grifols, Novartis, CSL Behring, Streamed up and RG Gesellschaft für Information und Organisation mbH. JMB received grants of the Thoraxstiftung Heidelberg and the Beatrice von Hardenberg Stiftung, consulting fees from Boehringer Ingelheim and Intuitive Surgical Inc as well as speaker fees from Boehringer Ingelheim, Astra Zeneca, Streamed up, Berlin Chemie, PulmonX and Olympus. RE received honoraria from Olympus and Pulmonx for lectures and educational activities. FH received speaker fees from Olympus and Pulmonx.

: Not applicable. There are no images or other personal or clinical details of participants included in this manuscript that might compromise anonymity.